Megan Holdings files to issue 15 million new shares, diluting shareholders
Key Facts
Megan Holdings filed a registration statement with the U.S. Securities and Exchange Commission on 20 October 2026 to issue up to 15 million Class A ordinary shares in a financing that would dilute existing shareholders. According to the prospectus, the offering involves new shares issued by the company, with proceeds going to the company to fund its stated purposes. Assumed maximum gross proceeds would total $8.25 million if the company sells all the shares offered at the assumed price used in the prospectus. After fees and expenses, Megan estimates net proceeds of about $7,418,232 if the sale is completed on that basis. These estimates depend on the number of shares sold and their pricing terms, with the transaction remaining at the proposed registration stage.
The scale of the proposed issuance stands out against the 1,066,700 Class A shares outstanding before the offering, according to the prospectus. If the offering is sold in full, the total number of shares in this class would rise to 16,066,700. Adding the new shares would expand the ownership base across which existing shareholders' stakes are spread, diluting their holdings in this class. The transaction would also affect the voting structure, with the company expecting Star Sprite's voting power to fall to about 35.0% if the full offering is sold. According to the disclosure, this would end Megan's controlled-company status, meaning completion of the issuance would both provide new funding and change voting control.
Under its planned use of proceeds, Megan intends to allocate the net proceeds to projects, acquisitions and general working capital. It expects to allocate 60% of net proceeds to projects and acquisitions, according to the use-of-proceeds table in the registration statement. It intends to allocate the remaining 40% to general working capital. The company described the financing purposes in the prospectus as "projects, acquisitions and general working capital," combining funding for expansion activities with funds for operating needs. This allocation is based on net proceeds after fees and expenses, so the funds available for each use depend on actual sale proceeds.
Megan develops, builds and maintains aquaculture farms and conducts related activities, with operations concentrated in Malaysia, according to its annual report filed with the U.S. regulator. The funding request follows an unaudited net loss for the six months ended 30 June 2026. That loss totaled 5,834,069 Malaysian ringgit, equivalent to $1,429,218, according to the dollar equivalent in the earnings disclosure. In its latest half-year results, revenue fell 8.4% year on year. The decline amounted to 1,167,502 Malaysian ringgit, placing the plan to allocate funds to projects, acquisitions and working capital after a period of losses and shrinking revenue.
Megan shares began trading on the Nasdaq Capital Market under the symbol MGN on 26 September 2025, according to its initial public offering closing announcement filed with the U.S. regulator. The company then closed a follow-on public offering on 27 February 2026. That offering comprised 20,750,000 Class A shares, based on the historical share count before the subsequent reverse split. Nasdaq later announced a reverse split of Megan shares at a ratio of one share for every 30 shares. The exchange set 17 September 2026 as the effective date of the split, preceding the new registration statement through which the company seeks to expand its share base again.
The next step for the registration statement filed on 20 October 2026 is for it to become effective before Megan can begin selling shares, under the terms of the prospectus. The company used an assumed price of $0.55 per share in its offering calculations. Final pricing remains subject to market conditions, making this price the basis for the disclosed financial estimates. The company also said in the registration statement: "There is no minimum offering amount required to complete the closing." This provision allows the transaction to close without raising a specified minimum amount, leaving final financing proceeds dependent on the shares sold and the price at which they are sold.